What the six lenses say about SMSPHARMA — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.
How SMSPHARMA’s own sector index is moving — context for reading the stock’s six lenses.
Six-lens read
The actual numbers
The actual numbers
Full 8-quarter history in the financials table below.
The actual numbers
The actual numbers
Every filing in the corporate-announcements panel below.
The actual numbers
Decile — each lens’s 0–100 score is ranked against every Micro-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.
Conviction — the average of the two active conviction-lens deciles (Technical & Flow):
Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.
Glass box
Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.
Policy
Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.
PLI Scheme — Pharmaceuticals & API
Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices
Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.
| Baseline | 1D | 1W | 1M | 3M | 6M | 12M |
|---|---|---|---|---|---|---|
Nifty 50 Large-cap anchor | +1.9pp | +8.3pp | +14.9pp | +5.1pp | +8.7pp | +66.9pp |
Nifty 500 Broad-market baseline | +1.8pp | +8.3pp | +13.8pp | +3.5pp | +2.9pp | +61.7pp |
Sector Own-sector index | — | — | +11.0pp | -2.6pp | -10.2pp | +40.9pp |
From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).
Trend
SMSPHARMA daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
SMSPHARMA ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
TradingView composite technical analysis — multi-timeframe consensus
Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.
| Metric | Jun '24 | Sep '24 | Dec '24 | Mar '25 | Jun '25 | Sep '25 | Dec '25 | Mar '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue (₹cr) | 164 | 197 | 173 | 248 | 196 | 242 | 210 | 238 |
| ↳ change QoQ | — | +19.6% | -11.9% | +43.1% | -21.0% | +23.5% | -13.2% | +13.3% |
| EBITDA (₹cr) | 35 | 33 | 35 | 41 | 39 | 48 | 44 | 40 |
| EBITDA margin | 21.2% | 16.7% | 20.4% | 16.5% | 19.9% | 19.8% | 20.9% | 16.8% |
| PAT (₹cr) | 16 | 14 | 18 | 20 | 20 | 25 | 23 | 33 |
| ↳ change QoQ | — | -14.4% | +29.4% | +9.6% | +0.0% | +25.0% | -8.0% | +43.5% |
| Net margin | 10.0% | 7.2% | 10.5% | 8.1% | 10.2% | 10.3% | 10.9% | 13.9% |
| EPS (₹) | 1.95 | 1.69 | 2.15 | 2.29 | 2.31 | 2.70 | 2.51 | 3.49 |
| D/E | — | — | — | — | — | — | — | — |
Filings to the exchange — capital actions, earnings and governance. Most recent first.
A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗…and 5 more.
Ownership
Mutual funds holding SMSPHARMA (1)
| Fund | Weight | AUM ₹cr | Grade |
|---|---|---|---|
| Quant Healthcare Reg Gr | 7.27% | 397 |
ETFs holding SMSPHARMA (0)
No tracked ETF holds SMSPHARMA ≥0.5%.